- Home
- AVO vs MYGN Comparison
AVO vs MYGN Comparison
Compare AVO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVO
- MYGN
- Stock Information
- Founded
- AVO 1983
- MYGN 1991
- Country
- AVO United States
- MYGN United States
- Employees
- AVO N/A
- MYGN N/A
- Industry
- AVO Farming/Seeds/Milling
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AVO Consumer Staples
- MYGN Health Care
- Exchange
- AVO Nasdaq
- MYGN Nasdaq
- Market Cap
- AVO 870.7M
- MYGN 744.7M
- IPO Year
- AVO 2020
- MYGN 1995
- Fundamental
- Price
- AVO $12.08
- MYGN $5.60
- Analyst Decision
- AVO Strong Buy
- MYGN Hold
- Analyst Count
- AVO 2
- MYGN 15
- Target Price
- AVO $15.50
- MYGN $15.14
- AVG Volume (30 Days)
- AVO 519.8K
- MYGN 1.6M
- Earning Date
- AVO 06-05-2025
- MYGN 08-05-2025
- Dividend Yield
- AVO N/A
- MYGN N/A
- EPS Growth
- AVO 108.17
- MYGN N/A
- EPS
- AVO 0.52
- MYGN N/A
- Revenue
- AVO $1,392,900,000.00
- MYGN $831,300,000.00
- Revenue This Year
- AVO $8.85
- MYGN N/A
- Revenue Next Year
- AVO N/A
- MYGN $6.68
- P/E Ratio
- AVO $23.34
- MYGN N/A
- Revenue Growth
- AVO 29.50
- MYGN 7.38
- 52 Week Low
- AVO $9.54
- MYGN $3.81
- 52 Week High
- AVO $15.25
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- AVO 58.90
- MYGN 59.81
- Support Level
- AVO $11.53
- MYGN $4.90
- Resistance Level
- AVO $12.10
- MYGN $5.74
- Average True Range (ATR)
- AVO 0.34
- MYGN 0.27
- MACD
- AVO -0.07
- MYGN 0.10
- Stochastic Oscillator
- AVO 47.01
- MYGN 85.71
About AVO Mission Produce Inc.
Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.